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Age-related macular degeneration (AMD) accounts for 8.7% of blind-
ness worldwide, and it is a leading cause of blindness in the United States 
among adults age 60 and older.1-3 Globally, about 1 in 32 visual impair-
ments and 1 in 15 cases of blindness are due to macular disease.4 Dry 
AMD is a degenerative condition that begins in Bruch’s membrane and 
progresses to the retinal pigment epithelium (RPE) and the overlying 
photoreceptors with loss of central vision. The RPE is a single layer of 
pigment cells lying between the photoreceptors and choriocapillaris. 
The functions of the RPE include light absorption, epithelial transport, 
phagocytosis, secretion, and immune modulation. All of these functions 
are important to maintaining and supporting the photoreceptors. High 
blood flow rate and high O2 saturation in the choriocapillaris render the 
RPE more exposed to oxidative stress.5
Oxidative stress seems to play a major role in the pathogenesis of dry 
AMD and retinal degeneration, although the pathophysiology of dry 
AMD is complex.5,6 The macula is subject to increased levels of photo-
oxidative stress because of its elevated metabolic rate and high propor-
tion of polyunsaturated fatty acids, which are highly susceptible to lipid 
peroxidation. As the RPE cells of the macula age, oxidation of lipids and 
other cellular components results in an accumulation of indigestible lipo-
fuscin in the lysosomes. The accumulation of lipofuscin granules closely 
parallels drusen formation in time course and distribution in the retina. 
Oxidative damage to the mitochondrial DNA in RPE cells has also been 
implicated in the development of AMD. Levels of antioxidants in retinal 
tissue, in particular glutathione (GSH), decrease with aging, making the 
macula even more vulnerable to progressive oxidative damage.7,8
Endogenous antioxidants, such as GSH, cannot be replaced directly. In-
stead, compounds that can easily enter cells and increase intracellular 
antioxidant levels are preferred. Dietary antioxidants have been shown 
to slow the progression of retinal degeneration and halt progression of 
AMD in human clinical trials.9,10 GSH and its amino acid precursors 
protect RPE cells from oxidative injury and oxidant-induced apoptosis 
in vitro. N-acetylcysteine amide (NACA), a GSH prodrug, is a promis-
ing candidate for use as an antioxidant-based treatment for AMD. It has 
demonstrated efficacy in numerous in vitro and animal models of other 
oxidative stress-related conditions, including drug-induced RPE dam-
age and cataracts.11-15 Our lab has demonstrated that NACA prevented 
retinal degeneration in vitro and in animal models.14 The immortalized 
ARPE-19 cell line was used as an in vitro model because primary human 
RPE cells were not available at the time. ROS generation and lipid per-
oxidation induced by tert-butyl hydroperoxide (TBHP) were reversed by 
pretreatment with NACA. NACA also protected against TBHP-induced 
cell damage by increasing cellular levels of GSH, and maintaining cellu-
lar integrity, as measured by transepithelial electrical resistance (TEER). 
In an animal model, phototoxicity-induced photoreceptor cell death and 
photoreceptor dysfunction were prevented by NACA.14
The experiments reported here utilized primary cultures of human reti-
nal pigment epithelial cells (HRPEpiC), the best available in vitro model 
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ABSTRACT
Background: Age-related macular degeneration (AMD) is a leading cause 
of blindness in the United States among adults age 60 and older. While 
oxidative stress is implicated in the pathogenesis of AMD, dietary anti-
oxidants have been shown to delay AMD progression in clinical studies. 
We hypothesized that N-acetylcysteine amide (NACA), a thiol antioxidant, 
would protect retinal pigment epithelium and impede progression of retinal 
degeneration. Methods: tert-Butyl hydroperoxide (TBHP) was used to in-
duce oxidative stress in cell cultures. The goal was to evaluate the efficacy 
of NACA in an in vitro model of AMD in primary human retinal pigment 
epithelial cells (HRPEpiC). Results: Our data indicates that TBHP gener-
ated reactive oxygen species (ROS), which reduced cell viability, depleted 
glutathione (GSH) levels, and compromised glutathione reductase (GR) 
activity. Pretreatment with NACA significantly reduced ROS generation, 
restored GSH levels and GR activity, and recovered transepithelial electrical 
resistance. Pretreatment with NACA did not decrease the number of dy-
ing cells as determined by flow cytometry analysis. However, survival was 
significantly improved when cells were co-exposed to NACA and TBHP af-
ter a shortened pretreatment period. Conclusion: Our data suggest that 
pretreatment with NACA reduces sublethal but not lethal effects of TBHP 
in HRPEpiC. NACA significantly improves cell survival when administered 
prior to and during oxidative damage similar to that observed in the devel-
opment of dry AMD. These results indicate that continuation of a thiol anti-
oxidant regimen for treatment of AMD is beneficial throughout the course 
of the disease, and NACA is a potent antioxidant that should be further 
evaluated for this purpose.
Key words: N-acetylcysteine amide, Thiol antioxidant, Oxidative free radi-
cal damage, Retinal pigment epithelium.
Key Messages: NACA defends RPE against oxidative stress in an in vitro 
model of AMD. 
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for studying RPE-related disorders. Because we attempted to mimic a hu-
man disease and provide a solution using a “disease-in-the-dish” model, 
choosing the most representative cell model was critical. Thus, we de-
cided to determine whether the beneficial effects of NACA observed in 
ARPE-19 cells could also be observed in the HRPEpiC. Our goals were 
to investigate the following: (1) the sublethal and lethal effects of TBHP 
in HRPEpiC and (2) the protective effects of NACA pretreatment against 
TBHP-induced oxidative damage. Sublethal effects included changes in 
redox status (ROS generation, GSH levels and GR activity) and mono-
layer integrity (TEER and dextran permeability). Lethal effects were de-
termined with cell viability and apoptosis assays.
MATERIALS AND METHODS
Materials
N-acetylcysteine amide (NACA) was provided by Dr. Glenn Goldstein 
(David Pharmaceuticals, New York, NY, USA). Human retinal pigment 
epithelial cells (HRPEpiC) were purchased from ScienCell Research 
Laboratories (Carlsbad, CA, USA). Other chemicals were ordered from 
Sigma (St. Louis, MO, USA), unless otherwise indicated.
HRPEpiC culture and experimental design
HRPEpiC were grown in complete media and divided in to 4 groups 
(control, NACA, TBHP and NACA+TBHP). Cells were pretreated with 
2 mM NACA (in NACA and NACA+TBHP groups) or serum-free me-
dia (in control and TBHP groups). After 4 h incubation, the media was 
removed, and followed by dosing with 0.5 mM TBHP for 3 h. For apop-
tosis assays, an alternative NACA and TBHP dosing protocol was used 
in addition to the one described above. This involved pretreatment with 
NACA for 1 h prior to TBHP exposure and addition of NACA for an-
other 3 h (i.e., the NACA+TBHP group cells were co-exposed to TBHP 
and NACA for 3 h). 
Cell viability assay
1×105 cells per well were seeded in a 96-well plate for 24 h before fur-
ther dosing. After cells were treated as indicated in the experimental de-
sign, 2 μM Calcein-AM (Biotium Inc., CA) was added to each well, and 
cells were incubated for 30 min before measuring the fluorescence by 
plate reader (λex = 485 nm and λem = 530 nm) (FLUOstar Omega, BMG 
Labtech).   
Intracellular ROS measurement
10 μM of CM-H2DCFDA (Molecular Probes, Life Technologies) was 
loaded prior to dosing according to the experimental design. Fluores-
cence was measured after treatment (λex = 485 nm and λem = 530 nm).
Quantification of intracellular glutathione (GSH) levels
Cells were grown at a density of 1.2×106 per 10-cm plate for 24 h be-
fore further treatment. GSH was separated and quantified by HPLC with 
fluorescence detection (Finnigan Surveyor FL Plus, Thermo Scientific) 
after derivatization of cell homogenates with N-(1-pyrenyl)maleimide 
(NPM).16
Glutathione reductase (GR) activity assay
Cells were homogenized in 250 μl of 50 mM Tris-HCl (pH = 7.5) con-
taining 1 mM EDTA. NADPH, which absorbs light at 340 nm, was added 
to each sample. The rate of its oxidation to NADP+ by GR as GSSG is 
reduced to 2 GSH can be determined from the resulting decrease in ab-
sorbance at this wavelength over time.17
Determination of Protein
Protein levels of the cell homogenates were measured by the Bradford 
method (BioRad Laboratories, Inc., CA, USA). Bovine serum albumin 
was used as the protein standard. 
Dextran permeability and transepithelial electrical 
resistance (TEER) measurement
12-mm Transwell inserts were coated with poly-L-lysine for 1 h prior 
to seeding 0.5 ml at 1×106 cells/ml. Cell growth was maintained for 5 
days without disturbing the monolayer. Fluorescently labelled dextrans 
(FD4, 1 mg/ml) were administered apically onto the insert after dosing. 
Fluorescence was read after 30 min (λex =485 nm and λem = 530 nm). The 
inserts containing the monolayer were then transferred to a new well 
with serum-free phenol red-free media and used for TEER measurement 
with an EVOM voltohmmeter (World Precision Instrument, Sarasota, 
FL, USA) to assess the integrity of HRPEpiC monolayer. 
Flow cytometry quantification of apoptotic cells 
Cells were grown in 6-cm plates and dosed as described by the experi-
ment design. Trypsinized cells were re-suspended in binding buffer 
containing 7-AAD and annexin V-FITC (BD Biosciences, San Jose, CA, 
USA). Cells were incubated for 15 minutes at room temperature in the 
dark then analyzed by Cell Lab Quanta SC flow cytometry (Beckman 
Coulter, Fullerton, CA, USA).
Statistical Analysis
All values are reported as mean ± SD (n = 3-10). Statistical analysis was 
performed using GraphPad Prism 5 software (GraphPad, San Diego, 
CA, USA). Statistical significance was performed by one-way analysis 
of variance (ANOVA), followed by Tukey’s multiple comparison tests. 
#, ## and ### represent P<0.05, 0.01 and 0.001, respectively, compared 
to control; *, ** and *** represent P<0.05, 0.01 and 0.001, respectively, 
compared to TBHP group. 
RESULTS
TBHP increased intracellular ROS levels in HRPEpiC, and 
NACA prevented ROS generation
To investigate ROS generation in response to TBHP treatment, ROS lev-
els were measured after exposing cells to TBHP for 3 h.  TBHP induced 
ROS generation in a dose-dependent manner (Figure 1A). ROS levels in 
TBHP-treated cells were 177% of those observed in the control group 
(P<0.001). Pretreatment with NACA decreased ROS levels to 126% of 
those observed in the control group (P<0.001 compared to TBHP group) 
(Figure 1B).
Dose-dependent GSH depletion by TBHP and revention 
by pretreatment with NACA 
To elucidate the consequences of elevated ROS in HRPEpiC, GSH levels 
were measured after treatment for 3 h with various concentrations of 
TBHP. TBHP decreased cellular GSH levels in a dose-dependent man-
ner: the average GSH levels in cells treated with 0, 0.5, 1, 25 and 50 mM 
TBHP were 33.4 ± 5.0, 25.1 ± 1.5, 18.9 ± 0.7, 8.8 ± 1.9 and 6.2 ± 1.3 nmol/
mg protein, respectively (P<0.001 compared to control) (Figure 2A). The 
protective effect of NACA on GSH depletion in cells treated with TBHP 
was also investigated (Figure 2B). GSH is the major antioxidant in the 
cell and NACA is a GSH precursor, providing cysteine for GSH synthe-
sis. The average GSH level in the control group was 31.7 ± 2.3 nmol/mg 
protein. The GSH level was increased after NACA incubation (55.1 ± 7.3 
nmol/mg protein, P<0.001 compared to control). The average GSH level 
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of  the TBHP group was 25.1 ± 1.5 nmol/mg protein (P<0.01 compared 
to control), but the NACA+TBHP group had an average GSH level of 
30.5 ± 2.5 nmol/mg protein (P < 0.05, compared to the TBHP group).
Preservation of glutathione reductase activity by 
pretreatment with NACA
Glutathione reductase (GR), an enzyme which reduces glutathione di-
sulfide to GSH, is important in restoring intracellular levels of GSH. GR 
activity was reduced in the TBHP group (33.5 ± 3.2 versus 21.9 ± 2.2 
mU/mg protein in the control group; P<0.01) (Figure 3). NACA-pre-
treated cells exhibited increased GR activity (33.5 ± 5.2 mU/mg protein; 
P<0.01 compared to the TBHP group).
Effects of oxidative stress on HRPEpiC monolayer 
paracellular permeability and contribution of NACA to 
monolayer functional homeostasis
RPE paracellular permeability was assessed in HRPEpiC grown on 
a polycarbonate insert, which form a monolayer similar to that of the 
blood-retina barrier in vivo. Transepithelial electrical resistance (TEER) 
was used as a measure of paracellular permeability to ions, where lower 
electrical resistance is evidence of decreased membrane integrity of HR-
PEpiC in the monolayer. Permeability to non-ionic molecules was deter-
mined based on the amount of dextran able to pass through the mono-
layer within 30 min. Compared to the TBHP group, the NACA+TBHP 
group exhibited significantly greater electrical resistance (Figure 4A). 
Dextran permeability in the TBHP group was significantly higher than 
control (P<0.05) (Figure 4B).
Cell viability and lethal effects of TBHP in HRPEpiC 
To investigate cell survival in response to ROS generation, cell viabil-
ity assays were performed after treatment (Figure 5). Pretreatment with 
NACA alone did not affect cell viability (91.1 ± 4.5%) compared to con-
trol (100.0 ± 10.1%). Cell viability was reduced in the TBHP group (52.2 
± 5.5%, P<0.001). Pretreatment with NACA provided slight but not sta-
tistically significant protection against TBHP-induced cell death.
Annexin V-FITC and 7-aminoactinomycin-D (7-AAD) 
detection of apoptosis by flow cytometry
NACA has multiple antioxidant properties. It is a well-known GSH pro-
drug and a free radical scavenger.18-20 In cell-free systems, NACA can 
non-enzymatically restore GSH through thiol-disulfide exchange with 
the oxidized form, GSSG.21 An annexin V-FITC and 7-AAD double 
staining assay was performed. Cells in the early apoptotic stages only 
bind annexin V-FITC, while cells in late apoptotic stages bind both an-
nexin-V-FITC and 7-AAD. Dead/necrotic cells may only exhibit 7-AAD 
fluorescence, due to membrane disintegration and subsequent loss of 
phosphatidylserine. Table 1 summarizes the percent distribution of vi-
able cells and cells in the early and late stages of apoptosis. The percent-
ages of viable cells in the TBHP and NACA+TBHP groups are very simi-
lar (64.0 ± 4.9 % versus 67.8 ± 9.9 %). There was no significant difference 
in the number of dying cells (defined as the total of early- and late-stage 
apoptotic cells) between the TBHP and the NACA+TBHP groups (20.5 
± 6.1% versus 20.8 ± 4.8%). Because no significant improvement was 
observed in the cells pretreated with NACA, the dosing protocol was 
modified slightly without changing the total NACA exposure time (see 
Methods). Results of the modified treatment protocol are shown in Fig-
ure 6 and Table 2. In the NACA+TBHP (co-exposed) group, the percent-
age of viable cells (88.6 ± 0.1%) was significantly higher than that in the 
TBHP group (48.5 ± 5.1%, P<0.001). The percentages of dying cells in 
the TBHP group and the NACA+TBHP co-exposure group were 16.5 ± 
3.6% and 5.5 ± 0.8%, respectively.
Figure 1: Intercellular ROS levels were measured using DCF fluorescence. 
(A) TBHP induced ROS generation in a dose-dependent manner. (B) NACA 
prevented TBHP-induced ROS generation.
Figure 2: Intracellular GSH levels in HRPEpiC. (A) TBHP depleted GSH levels 
in a dose-dependent manner. (B) NACA dramatically increased intracellular 
GSH levels and prevented GSH depletion by TBHP.
Figure 3: Preservation of glutathione reductase activity by NACA.
Table 1:  Percent distribution of viable cells and cells in the early and 
late stages of apoptosis after 4 h pretreatment with NACA followed by 







Viable cells 94.8 ± 1.3 93.7 ± 0.5 64.0 ± 4.9 67.8 ± 9.9
Early 
apoptotic cells 1.3 ± 0.6 3.0 ± 1.1 1.8 ± 0.8 2.1 ± 0.4
Late apoptotic 
cells 1.9 ± 0.2 2.1 ± 0.5 18.8 ± 5.4 18.6 ± 4.9
The results are shown as mean % of total cells ± SD.
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Figure 4: Protective effects of NACA on paracellular permeability in HR-
PEpiC. (A) Results of TEER measurement. (B) Results of dextran permeability 
assays.
Figure 5: Effects of NACA and TBHP on HRPEpi cell viability. 
Figure 6: Flow cytometry analysis of apoptotic cells following the modi-
fied (co-exposure) protocol with NACA and TBHP. The dot plots show two-
parameter analysis of fluorescence intensity of annexin-V FITC (FL1) and 
7-AAD (FL3).
DISCUSSION
In this study, we evaluated the potential of NACA to prevent oxidative 
stress-related damage in vitro in HRPEpiC. This allowed for evaluation 
of NACA as a defense against TBHP-induced oxidative injury. Selection 
of the best in vitro analogue to RPE in AMD patients was vital to the 
clinical relevance of our results. Currently, there are three cell models 
used to study the effects of oxidative stress on the RPE: ARPE-19, fetal 
human RPE cells (fhRPE) and primary culture adult human RPE (e.g., 
HRPEpiC). ARPE-19 is a spontaneously arising retinal pigment epithe-
lial cell line derived from normal eyes. The fhRPE and HRPEpiC are pri-
mary cultures of fetal and adult human RPE cells, respectively.  When 
compared to ARPE-19, fhRPE cells are healthier; however, adult human 
RPE are more physiologically representative of the mature function of 
RPE than fhRPE.22,23 Thus, an adult human primary RPE cell model was 
implemented for the experiments detailed here.  
The RPE of the macula is particularly vulnerable to oxidative damage 
due to increased O2 exposure, photo-oxidation, elevated metabolic activ-
ity, and high proportion of polyunsaturated fatty acids.5 Our data dem-
onstrates that TBHP increased ROS levels in a dose-dependent man-
ner, leading to severe oxidative stress in the HRPEpiC cultures. NACA 
pre-incubation prevented TBHP-induced ROS production in HRPEpiC. 
It has been shown that accumulation of ROS induces severe oxidative 
stress in RPE cells, which is manifested by significant reduction in levels 
of GSH (the most critical antioxidant and redox buffer of the cell).24,25 
Results from our study showed a significant decrease in GSH levels in 
the HRPEpiC when compared to those of the control group (Figure 2). 
Pretreatment with NACA significantly increased GSH levels. This may 
indicate that NACA replenished GSH levels, leading to reversal of oxida-
tive stress. The protective effects of NACA are probably mediated by a 
number of pathways, which may include supplying cysteine for GSH bio-
synthesis, reduction of extracellular cystine to cysteine, and conversion 
of GSSG to GSH by the action of GR and by non-enzymatic thiol disul-
fide exchange.12,26-28 Our results are in agreement with previous studies 
which reported an increase in GSH levels after NACA incubation and a 
decrease in GSH levels upon TBHP treatment in an ARPE cell line.11,14
Importantly, changes in the GR activity were also observed. GR regener-
ates GSH from GSSG  and plays an important role in GSH homeostasis.29 
NACA treatment increased the levels of GSH and restored GR activity 
(Figure 3). Our results are in line with another study that reported inhi-
bition of GR activity in HepG2 upon TBHP treatment.30
In the retina, the RPE forms the blood-retinal barrier (BRB) with tight 
junctions that control the exchange of nutrients and metabolites between 
the retina and the underlying choriocapillaris. It is thought that oxida-
Table 2:  Percent distribution of viable cells and cells in the early and 




0.5 mM  
TBHP 
NACA+TBHP 
Viable cells 90.4 ± 1.2 84.8 ± 4.2 48.5 ± 5.1a 88.6 ± 0.0b
Early apoptotic 
cells 2.2 ± 0.3 1.7 ± 0.9 2.2 ± 1.0 2.3 ± 0.3
Late apoptotic 
cells 2.5 ± 0.4 4.4 ± 0.2 14.3 ± 3.5 3.1 ± 0.5
The results are shown as mean % of total cells ± SD. (a, P < 0.001 compared to 
control group; b, P < 0.001 compared to TBHP group).
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tive stress may induce changes in the BRB, which may contribute to the 
pathogenesis of retinal degeneration. To investigate the ability of NACA 
to preserve BRB function, membrane integrity after TBHP exposure was 
evaluated using dextran permeability and TEER assays.31 NACA pre-
vented TBHP-induced reduction in TEER, verifying its ability to pro-
tect cellular homeostasis and outer BRB integrity under severe oxida-
tive stress conditions. A similar decrease in TEER has been reported in 
another study, where human embryonic stem cell (hESC)-derived RPE 
cells and ARPE-19 cells were exposed to hydrogen peroxide.31,32 These re-
sults are also in agreement with a previous study performed in our labo-
ratory using the ARPE-19.14 However, we did not observe any significant 
difference in dextran permeability upon NACA treatment, which could 
be due to lower sensitivity of dextran permeability when compared with 
TEER.33
The decline in GSH observed creates a redox imbalance that enhances 
cell susceptibility to injury and ROS-induced apoptosis. Altering the re-
dox state to a more reduced environment by addition of GSH has been 
shown to decrease sensitivity of RPE cells to apoptosis from ROS.34,35 
We initially investigated the protective effect of NACA pretreatment by 
studying cell viability. However, no significant improvement was noted 
in cell survival using either the Calcein-AM assay or flow cytometry. 
We therefore modified our study design to include co-exposure along 
with pre-incubation and dramatically improved cell survival (Figure 6). 
It is possible that pretreatment alone is not sufficient to address mul-
tiple oxidative stress-related apoptotic mechanisms. Oxidants, such as 
TBHP, may induce apoptosis through two different pathways: (1) Fas-Fas 
ligand activation and (2) mitochondrial damage and subsequent release 
of cytochrome c.36 Because the interplay of these two pathways is com-
plex, it is plausible that antioxidant treatments, while producing a more 
favorable redox status in the cell, may not fully address both apoptotic 
pathways.  In addition, concentrations of TBHP (0.5 mM) and NACA (2 
mM) chosen for our investigation may be too high and low, respectively, 
to observe significant cytoprotection by pretreatment with NACA. Our 
previous studies with ARPE-19 indicate that up to 10 mM NACA may be 
used to beneficial effect as a pretreatment for 0.4 mM TBHP exposure.14 
CONCLUSION
This study demonstrates that treatment of retinal pigment epithelium 
with NACA protected against oxidative stress-induced cellular injury. 
NACA also inhibited oxidative stress-related breakdown of the blood-
retinal barrier as measured by TEER. The proposed mechanism of ac-
tion involves NACA scavenging existing ROS and increasing levels of 
reduced glutathione. With the prevalence of AMD and other retinal 
degeneration disorders expected to double in the coming decades, the 
development of more effective therapies to prevent its progression is im-
perative. Our results indicate that NACA has the potential to become 
an effective therapeutic agent by enhancing antioxidant defenses while 
removing pathologically relevant ROS. 
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GR: Glutathione reductase; GSH: Glutathione; GSSG: Reduces glutathi-
one disulfide; HRPEpiC: Primary human retinal pigment epithelial cells; 
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PICTORIAL ABSTRACT
• TBHP increased intracellular ROS levels in HRPEpiC, and NACA prevent-
ed ROS generation. 
• Dose-dependent GSH depletion by TBHP was prevented by pretreatment 
with NACA.
• Pretreatment with NACA preserved of GR activity.
• NACA inhibited oxidative stress-related breakdown of HRPEpiC mono-
layer paracellular permeability.
• NACA significantly improved cell survival when administered prior to and 
during oxidative damage.
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